Michael Traxlmayr, PhD profile page

Michael Traxlmayr did his undergraduate studies at BOKU University (Vienna, Austria), followed by a PhD in the field of antibody engineering in the lab of Prof. Christian Obinger (BOKU). Next, he worked as a postdoc in the lab of Prof. Dane Wittrup at MIT (Cambridge, USA), where he engineered non-antibody-based domains for specific antigen binding. After returning to Vienna, he started to apply his protein engineering skills in the field of CAR T cell cancer immunotherapy in collaboration with Dr. Manfred Lehner (CCRI, Vienna). Since 2019, Michael Traxlmayr is the head of the BOKU-module of the "CD Laboratory for Next Generation CAR T Cells" and his current research focuses on engineering novel protein tools to enable regulation of CAR T cell activity with small molecule drugs and to improve the tumor specificity of CAR T cells.